Table:
begin	end	state
1	11	cytoplasmic
12	32	transmembrane
33	51	non-cytoplasmic
52	72	transmembrane
73	81	cytoplasmic
82	101	transmembrane
102	109	non-cytoplasmic
110	133	transmembrane
134	144	cytoplasmic
145	166	transmembrane
167	179	non-cytoplasmic
180	200	transmembrane
201	233	cytoplasmic
234	256	transmembrane
257	269	non-cytoplasmic
270	291	transmembrane
292	298	cytoplasmic
299	318	transmembrane
319	323	non-cytoplasmic
324	346	transmembrane
347	357	cytoplasmic
358	378	transmembrane
379	383	non-cytoplasmic
384	403	transmembrane
404	410	cytoplasmic

Input:
>WP_091369124.1 NCBI__GCF_900105165.1:WP_091369124.1
MDQKPAFTEPKYRVILFFVTALFMLWGIAITLGDVLNRHFQNVLHISKSHSGLVQLSIFG
AYAVMGIPAGLFMKRFGYKKGILLGLFLYAFGAFLFVPAADAVSFDFFRIALFILACGLA
TLETVAHPFVAALGDQRTSDQRINFSQAFNGLGGVIGPTLGGYFILKGQQIHSNDLIAVK
YLYVIIGSVIVLIGVLFLFLKVPHLTHAHNEVIDYENAEGNKKIEKKLIHQKHYVFAVVA
QFFNVAAQGGTWAYFINYGHEMVHLSDERAAYFFSLSMIMLMIGRFTGTFLMRYIAPYRL
LSIFAAANIVMCLIVAQGAGWLSFIALLFINFFFSIMFPTIFSLGLKNLGGKTQQGSSFI
VMGVIGGGLFPPLMGLIANHDIAAAYYLPIICYIVIFLFGYCYPRLAKPN

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server